A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

Part of paid clinical trials in Lincoln, California.

Sponsor
AstraZeneca
Study ID
NCT07606066
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Procedure: assessment — OTHER
    The approximate volume of blood required is 2 mL

Study Details

The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient population across different geographical regions.

Key Dates

Start date
May 6, 2026
Status verified
May 2026
Primary completion
Mar 31, 2027
Completion
Mar 31, 2027

Study Design

Enrollment
3,000 participants (estimated)

Arms

  • Arm: Participants with Type 2 Diabetes
    Participants with Type 2 Diabetes

Primary Outcome Measure

Patient demographics [ Time Frame: Visit 1 (Single day) ]

Central Contacts

Locations (6)

FacilityCityStateZIPSite coordinators
Research SiteLincolnCalifornia95648-
Research SiteOcoeeFlorida34761-
Research SiteDecaturGeorgia30030-
Research SitePotomacMaryland20854-
Research SiteGaffneySouth Carolina29340-
Research SiteRentonWashington98057-

Find similar trials in Lincoln, CA

By condition
Type 2 diabetes
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
Research Site· Lincoln, CAResearch Site· Ocoee, FLResearch Site· Decatur, GAResearch Site· Potomac, MDResearch Site· Gaffney, SCResearch Site· Renton, WA

Related Studies